84 results on '"McGlynn, Katherine A."'
Search Results
2. Cancer incidence in the US military: An updated analysis
3. Biomarkers of gut barrier dysfunction and risk of hepatocellular carcinoma in the REVEAL‐HBV and REVEAL‐HCV Cohort Studies
4. Age‐incidence patterns of seminoma and nonseminoma among males and females in Germany and the United States, 2008–2016
5. Prediction of nonalcoholic fatty liver disease using anthropometry and body fat measures by sex and race/ethnicity in the United States
6. Editorial: higher levels of certain serum bile acids in non‐alcoholic fatty liver disease–new insights from Guatemala.Authors’ reply
7. Letter: association of circulating bile acid concentrations and non‐alcoholic fatty liver disease—authors’ reply
8. Letter: is it appropriate to use a fatty liver index >60 as an alternative criterion for non‐alcoholic fatty liver disease? Authors’ reply
9. Circulating bile acid concentrations and non‐alcoholic fatty liver disease in Guatemala
10. Frequency of thePNPLA3rs738409 polymorphism and other genetic loci for liver disease in a Guatemalan adult population
11. Global patterns in testicular cancer incidence and mortality in 2020
12. Associations between aflatoxinB 1‐albumin adduct levels with metabolic conditions in Guatemala: A cross‐sectional study
13. Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus‐ and hepatitis C virus‐infected individuals
14. Tumour size and overall survival among surgically treated patients with non‐metastatic colon cancer in the U.S. Military Health System
15. Associations betweenHelicobacter pyloriwith nonalcoholic fatty liver disease and other metabolic conditions in Guatemala
16. Prediagnostic concentrations of circulating bile acids and hepatocellular carcinoma risk: REVEAL‐HBV and HCV studies
17. Analysis ofTP53aflatoxin signature mutation in hepatocellular carcinomas from Guatemala: A cross‐sectional study (2016‐2017)
18. One‐carbon metabolism‐related micronutrients intake and risk for hepatocellular carcinoma: A prospective cohort study
19. Have incidence rates of liver cancer peaked in the United States?
20. Survival among patients with glioma in the US Military Health System: A comparison with patients in the Surveillance, Epidemiology, and End Results program
21. The association between etiology of hepatocellular carcinoma and race‐ethnicity in Florida
22. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012
23. Testicular cancer incidence predictions in Europe 2010–2035: A rising burden despite population ageing
24. Abdominal and gluteofemoral size and risk of liver cancer: The liver cancer pooling project
25. International trends in hepatocellular carcinoma incidence, 1978–2012
26. Postbiliary drainage rates of cholangitis are impacted by procedural technique for patients with supra‐ampullary cholangiocarcinoma: A SEER‐Medicare analysis
27. Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013
28. Associations between autoimmune conditions and hepatobiliary cancer risk among elderly US adults
29. Childhood height and risk of testicular germ cell tumors in adulthood
30. Metformin use and survival after non-small cell lung cancer: A cohort study in the US Military health system
31. Adiposity across the adult life course and incidence of primary liver cancer: The NIH-AARP cohort
32. Future of testicular germ cell tumor incidence in the United States: Forecast through 2026
33. International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007
34. Association between serum 25‐hydroxyvitamin D and serum sex steroid hormones among men in NHANES
35. Population attributable fractions of risk factors for hepatocellular carcinoma in the United States
36. Does Angiotensin‐Converting Enzyme Inhibitor and β‐Blocker Use Reduce the Risk of Primary Liver Cancer? A Case–Control Study Using the UK Clinical Practice Research Datalink
37. Menopausal hormone therapy use and risk of primary liver cancer in the clinical practice research datalink
38. A novel method for identifying settings for well-motivated ecologic studies of cancer
39. Incidence of testicular germ cell tumors among US men by census region
40. Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer
41. Breast reconstruction after mastectomy among Department of Defense beneficiaries by race
42. Fibrolamellar hepatocellular carcinoma in the USA, 2000–2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database
43. Surveillance mammography among female Department of Defense beneficiaries
44. Congenital malformations and testicular germ cell tumors
45. The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States
46. Dichlorodiphenyltrichloroethane and risk of hepatocellular carcinoma
47. Racial variation in tumor stage at diagnosis among Department of Defense beneficiaries
48. Racial variation in breast cancer treatment among Department of Defense beneficiaries
49. Sex disparities in colorectal cancer incidence by anatomic subsite, race and age
50. Risk of cancer in a large cohort of U.S. veterans with diabetes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.